The UK MDR and The EU MDR: What Are The Differences?



The single biggest difference is that they are no longer the same regulation. Great Britain runs on the UK Medical Devices Regulations 2002 (as amended) with its own UKCA mark and MHRA oversight, while the EU runs on Regulation (EU) 2017/745 with the CE mark, and a device approved under one does not automatically qualify under the other.
Summary comparison added per instructions:
| UK (Great Britain) | EU | |
| Governing law | UK Medical Devices Regulations 2002, as amended | Regulation (EU) 2017/745 (MDR) |
| Conformity mark | UKCA (CE currently also accepted, transitionally) | CE |
| Regulator | MHRA | National competent authorities in each member state |
| Third-party body | UK Approved Body | EU Notified Body |
| Local representative | UK Responsible Person | EU Authorized Representative |
UK MDR is the primary standard that mandates requirements for anyone selling medical products in the UK, as it is a vast market that often goes unexplored. After the UK left European Union, there has been some confusion regarding the regulations for medical devices in the UK, mostly whether one’s device is eligible to be sold in the UK with the exact specifications they are sold in the EU. Understanding the differences starts with a clear grasp of EU MDR compliance requirements — [our checklist covers everything you need]. As a result, some companies have decided to skip marketing in the UK altogether and are only selling in the rest of the EU countries. Let’s look closely at the UK regulations to help you understand how.
However, as anyone would agree, the UK market is enormous. There is good news for those who hold out and still want to market their products in both UK and EU. A close look at the current UK MDR regulations shows that very little to no alteration is necessary for most products.
The MHRA is the UK’s licensing authority for medical devices, and manufacturers must conform to its requirements before placing a device on the UK market.
The MHRA (Medicines and Healthcare products Regulatory Agency) is a government department in the United Kingdom. It is responsible for licensing all medical devices and medicines in the UK, including those imported from other European Union countries. To place your medical devices in the UK market, you must conform to the UK MHRA.
The MHRA has several vital documents that specify by whom and how a medical device can be marketed in the UK.
Generally, a manufacturer’s job will include: identifying which products are regulated and what regulations apply to them; providing required information about the product; complying with safety standards set by the MHRA; and submitting post-market surveillance reports as necessary. In short, the entire process is very similar to the EU.
As for the individual device requirements in terms of CER and literature review, the UK MDR regulatory framework is pretty similar to the MDD.
Manufacturers and their devices must be registered with the MHRA, with specific requirements depending on whether the manufacturer is UK-based or not.
As we mentioned earlier, all manufacturer and their devices must be registered in the MHRA. In addition, of course, there are also conformity assessment requirements for the products.
Some of the notifiable steps and key points regarding the MHRA and UK regulations are as follows.
The countries of Great Britain: England, Wales, and Scotland follow the UK MDR 2002 law. So, the devices need to conform to this document. According to the official site, the devices that will need to be registered are:
The UK will only accept products from a UK-based manufacturer. If one is not UK based, they will need to appoint a UK citizen who holds specific responsibilities that include ensuring the declaration of conformity and technical documentation are available, providing the MHRA with necessary information and documentation for demonstration of the conformity of a device, and many more.
For each new registration or any changes to the existing one, a fee of £100 has to be paid.
The Northern Ireland-based manufacturers can freely place their products in the UK market as they have already been through the MHRA registration.
According to the UK government, non-sterile and non-measuring devices that fall into the Class I category and IVDs can get their UKCA marking without any notified body. Other devices that require conformity assessment will need UK approved body. They are similar to notified bodies from the EU. The EU will also no longer recognize notified bodies from the UK. So, if your device, one sold in the EU, has been certified by a notified body from the UK, you may need to go through the conformity assessment again. The UK-notified bodies are now UK-approved bodies.
As the UK follows the directives mentioned above, the requirements for UK-appointed UKCA markings are also based on the relevant annexes of these directives.
It may surprise the manufacturers of the EU market, which have moved on to the more refined MDR. Note that neither the MDR nor the IVDR took effect before or during the transition period. This means the UK cannot enforce the MDR or IVDR. Hence, the UK MDR is being undertaken.
The UK currently accepts CE-marked devices under transitional rules that run until June 30, 2028 (MDD-based) or June 30, 2030 (MDR/IVDR-based), so manufacturers already CE-marked in the EU don’t need to start over for the UK market.
The process will be much easier for those who already have their product in the EU market and are looking to place their product in the UK. This is because the UK government gives several benefits for EU-certified medical devices. For example:
GBP 100, charged per new registration and again for any change to an existing one. This applies whether the manufacturer is based in the UK or appoints a UK Responsible Person to register on their behalf, and it’s separate from any EU registration or notified body costs a manufacturer selling in both markets would also carry. The fee covers the MHRA’s device registration system rather than any conformity assessment work.
As of August 2026, CE-marked devices under the old EU Medical Devices Directive are accepted in Great Britain until June 30, 2028, and CE-marked devices under EU MDR or EU IVDR are accepted until June 30, 2030. These are transitional dates, not permanent recognition, and the MHRA ran a consultation that closed April 10, 2026 on extending the MDD-based deadline and on recognizing EU MDR and IVDR CE marks indefinitely. A manufacturer relying on this transitional window should still plan for UKCA certification before the relevant deadline, since a CE mark alone does not carry over once recognition ends for that device type.
No. Since Brexit, the EU treats UK conformity assessment bodies as UK Approved Bodies rather than EU Notified Bodies, and their certifications aren’t valid for placing a device on the EU market. A device previously certified by a UK body for EU sale needs to go through conformity assessment again with an EU notified body. This cuts both ways: EU notified bodies also can’t certify a device for the UK market, which is why the UK maintains its own separate UK Approved Body system.
UK MDR 2002 is built on the three EU directives that predate the EU MDR and IVDR: Directive 90/385/EEC (AIMDD, for active implantable devices), Directive 93/42/EEC (MDD, for general medical devices), and Directive 98/79/EC (IVDD, for in vitro diagnostics). The UK has not adopted the newer EU MDR (2017/745) or IVDR (2017/746), which is the root cause of the divergence between the two systems. This means a device’s UKCA-relevant technical documentation is still assessed against the older directive framework, even though its EU CE-marking file would follow the newer, stricter MDR or IVDR requirements.
[/fusion_builder_container
Literature reviews, CERs, post-market surveillance — in one platform.